All stock lists
Lineage Cell Therapeutics, Inc. (LCTX)
NYSE: LCTX · Real-Time Price · USD
Healthcare · Biotechnology
$0.80-$0.12 (-13.07%)
Insider Score
76/ 100
LCTX Insider Score
Bullish1 qualifying trade · 1 insider · $17.10K bought in the last 90 days
LCTX Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $1.43 M | $1.07 M | $1.73 M | $6.61 M | $3.68 M | — |
| Revenue Growth (YoY) | -61.04 % | — | — | — | — | — |
| Cost of Revenue | $5.00 K | $0.00 | $0.00 | $66.00 K | $5.00 K | — |
| Gross Profit | $1.43 M | $1.07 M | $1.73 M | $6.54 M | $3.68 M | — |
| SG&A Expense | $4.92 M | $5.22 M | $5.08 M | $4.85 M | $4.19 M | — |
| R&D Expense | $3.82 M | $4.77 M | $4.23 M | $8.24 M | $3.27 M | — |
| Operating Expenses | $8.74 M | $9.99 M | $9.32 M | $13.09 M | $7.46 M | — |
| Operating Income | -$7.31 M | -$8.92 M | -$7.59 M | -$6.55 M | -$3.79 M | — |
| Pretax Income | $4.71 M | $1.54 M | -$4.79 M | -$4.39 M | -$29.75 M | — |
| Tax Provision | $484.00 K | — | — | — | $0.00 | — |
| Net Income | $4.23 M | $1.48 M | -$4.81 M | $851.00 K | -$29.78 M | — |
| EPS (Basic) | -$0.02 | $0.01 | -$0.02 | — | -$0.13 | -$0.13 |
| EPS (Diluted) | -$0.03 | $0.01 | -$0.03 | — | -$0.13 | -$0.13 |
| Shares Outstanding | 252.91 M | 249.50 M | 245.03 M | — | 228.85 M | 228.36 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
